3-溴吲哚-5-甲酸甲酯 | 916179-88-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 3-溴吲哚-5-甲酸甲酯
• 中文别名: 3-溴吲哚-5-羧酸甲酯
• 英文名称: methyl 3-bromo-1H-indole-5-carboxylate
• 英文别名: Methyl 3-bromoindole-5-carboxylate
• CAS: 916179-88-9
• 化学式: C₁₀H₈BrNO₂
• 分子量: 254.083
• InChiKey: NSZAFPUTJXZLKC-UHFFFAOYSA-N

物化性质

• 沸点：
  386.2±22.0 °C(Predicted)
• 密度：
  1.629

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  42.1
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 3-bromoindole-5-carboxylate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 3-bromoindole-5-carboxylate
CAS number: 916179-88-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C10H8BrNO2
Molecular weight: 254.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-溴吲哚-5-甲酸甲酯 在 四(三苯基膦)钯 、 potassium carbonate 、 sodium hydroxide 作用下， 以 乙醇 、 水 、 二甲基亚砜 、 甲苯 为溶剂， 反应 42.5h， 生成 methyl (E)-3-(furan-3-yl)-1-(hepta-4,6-dien-1-yl)-indole-5-carboxylate
  参考文献：
  名称：

  钯（II）催化的C ？H激活级联序列的多杂环形成。

  摘要：

  多杂环存在于许多天然产物中，并且在功能材料和药物设计中是有用的部分。作为合成花粉生物碱的计划的一部分，已经开发了一种新型的钯（II）催化的CH活化策略来构建此类系统。从简单的1,3-二烯基取代的杂环开始，可以一步合成大量包含吡咯，吲哚，呋喃和噻吩部分的多环系统。

  DOI：

  10.1002/anie.201501037
• 作为产物：
  描述：

  吲哚-5-甲酸甲酯 在 N-溴代丁二酰亚胺(NBS) 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 3.0h， 以56%的产率得到3-溴吲哚-5-甲酸甲酯
  参考文献：
  名称：

  钯（II）催化的C ？H激活级联序列的多杂环形成。

  摘要：

  多杂环存在于许多天然产物中，并且在功能材料和药物设计中是有用的部分。作为合成花粉生物碱的计划的一部分，已经开发了一种新型的钯（II）催化的CH活化策略来构建此类系统。从简单的1,3-二烯基取代的杂环开始，可以一步合成大量包含吡咯，吲哚，呋喃和噻吩部分的多环系统。

  DOI：

  10.1002/anie.201501037

文献信息

• Rhodium(III)-Catalyzed Regioselective Direct C-2 Alkenylation of Indoles Assisted by the Removable N-(2-Pyrimidyl) Group
  作者：Binwei Gong、Jingjing Shi、Xiaowei Wang、Yunnan Yan、Qiu Li、Yanqiu Meng、H. Eric Xu、Wei Yi

  DOI：10.1002/adsc.201300700

  日期：2014.1.13

  synthesis of C‐2‐alkenylindoles through rhodium(III)‐catalyzed direct CH functionalization of indoles with acrylates under air by employing a metal‐directing group strategy. This strategy gives a rare selectivity for the alkenylation N‐(2‐pyrimidyl)indoles at the C‐2 position and provides the functionalized C‐2‐ alkenylindoles under mild conditions with broad substrate tolerance. An expansion of the

  C-2-烯基吲哚单元是众多天然产物和药效团的关键组成部分。然而，在有机合成中，核心结构基序的分子间直接构建仍然具有挑战性。在这里，我们报告一种新型，高效，和通用的方法对C-2-alkenylindoles通过铑（III）合成的催化的直接Ç 通过采用金属导向基团策略，在空气中用丙烯酸酯对吲哚进行H官能化。该策略为C-2位置的烯基化N-（2-嘧啶基）吲哚提供了罕见的选择性，并在温和条件下提供了功能化的C-2-烯基吲哚，具有宽泛的底物耐受性。还已经证明了方法的扩展，例如，吡咯的直接烯基化和嘧啶基的容易的脱保护。所有结果表明，该方法可作为直接构建生物学上重要的C-2-烯基吲哚的极具吸引力的替代方法。
• SELECTIVE HDAC1 AND HDAC2 INHIBITORS
  申请人：Acetylon Pharmaceuticals, Inc.

  公开号：US20140128391A1

  公开（公告）日：2014-05-08

  Provided herein are compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with HDAC activity, particularly diseases or disorders that involve activity of HDAC1 and/or HDAC2. Such diseases include cancer, sickle-cell anemia, beta-thalassemia, and HIV.

  提供的是化合物、包含此类化合物的药物组合物，以及使用此类化合物来治疗或预防与HDAC活性相关疾病或失调的方法，尤其是涉及HDAC1和/or HDAC2活性的疾病。这些疾病包括癌症、镰状细胞性贫血、β-地中海贫血和HIV。
• [EN] INDOLE DERIVATIVES USEFUL AS PPAR ACTIVATORS<br/>[FR] DÉRIVÉS D'INDOLE UTILES COMME ACTIVATEURS DE PPAR
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2009047240A1

  公开（公告）日：2009-04-16

  There is provided according to the invention novel compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof: (I) useful as PPAR activators.

  根据本发明提供了化合物的新颖结构式(I)或其药学上可接受的盐或溶剂：(I)，可用作PPAR激活剂。
• [EN] OXADIAZOLE DERIVATIVES AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS D'OXADIAZOLE ET LEUR UTILISATION COMME MODULATEURS DES RÉCEPTEURS NICOTINIQUES DE L'ACÉTYLCHOLINE
  申请人：GLAXO GROUP LTD

  公开号：WO2009071577A1

  公开（公告）日：2009-06-11

  Oxadiazole derivatives of formula (I) where ring A is a bicyclic or tricyclic system. Claimed compounds are active on nicotinic acetylcholine receptors (nAChRs), and are useful to treat neurological, psychiatric, and gastrointestinal disorders, as well as sepsis and obesity.

  Oxadiazole衍生物的化学式（I），其中环A是一个双环或三环系统。所述化合物对尼古丁型乙酰胆碱受体（nAChRs）具有活性，并可用于治疗神经系统、精神病学和胃肠道疾病，以及败血症和肥胖症。
• Treatment of protein folding disorders
  申请人：Carter D. Michael

  公开号：US20070015813A1

  公开（公告）日：2007-01-18

  In certain embodiments, the invention is directed to a method for treating a protein folding disorder comprising administering to a subject a compound of the formulas disclosed. In preferred embodiments, the compounds are bis-indole compounds.

  在某些实施例中，本发明涉及一种治疗蛋白质折叠紊乱的方法，包括向受试者给予公开的配方的化合物。在优选实施例中，这些化合物是双吲哚化合物。